Pfizer (PFE) Named Global Top Pick at Jefferies

Jefferies analyst Jeffrey Holford made Pfizer (NYSE: PFE) its Global 'Top Pick' in the sector while reiterating a Buy rating and price target of $47.

Holford expects fundamentals and self help through M&A and restructuring to drive outperformance.

AbbVie (NYSE: ABBV), which is in 2nd place, remains significantly undervalued in their view. The firm maintained a Buy rating and trimmed its price target to $85.

For an analyst ratings summary and ratings history on Pfizer click here. For more ratings news on Pfizer click here.

Shares of Pfizer closed at $31.96 yesterday.

You May Also Be Interested In

• Freedom Broker Upgrades Halliburton (HAL) to Hold
• D.R. Horton (DHI) PT Raised to $125 at RBC Capital
• GE Vernova (GEV) PT Raised to $1,338 at Oppenheimer